Singapore’s Cancer Drug List (CDL) determines which outpatient cancer drug treatments are eligible for MediShield Life, MediSave and Integrated Shield Plan coverage, and the treatment must also match the listed clinical indication. Even when a drug is on the CDL, deductibles, co-insurance, claim limits and rider benefits can affect how much you still need to pay, while some riders may provide limited cover for non-CDL treatments.
The Ministry of Health maintains Singapore’s Cancer Drug List (CDL), which identifies outpatient cancer drug treatments that MediShield Life can cover. Each treatment on the list has a MediShield Life claim limit and a MediSave withdrawal limit. The treatment must also match the clinical indication stated on the CDL before these financing options can apply.
If a treatment qualifies, MediShield Life and an Integrated Shield Plan will contribute towards the cost. Being listed does not mean the treatment is fully covered. The clinical indication, deductibles, co-insurance, applicable claim limits, and any IP rider attached to the policy can all affect how much remains payable.
Coverage depends on the drug, its clinical indication, your Integrated Shield Plan, your rider, and the applicable claim limits rather than the drug name alone.
What is the cancer drug list?
The Cancer Drug List in Singapore is the Ministry of Health framework that identifies outpatient cancer drug treatments claimable under MediShield Life. Each treatment has its own MediShield Life claim limit and MediSave withdrawal limit. MOH last updated the list on 31 May 2026, so check the latest version when reviewing treatment coverage.
The CDL is not simply a list of individual drug names. The clinical indication matters too. A cancer drug appearing on the list does not automatically mean every use of that drug qualifies as a CDL treatment.
The CPF Board states that cancer drug treatments must meet the relevant clinical indication in full to be claimable. You therefore need to check both the drug and the specific medical reason your doctor is prescribing it for.
What changed with the cancer drug list?
The CDL framework changed how MediShield Life, MediSave and Integrated Shield Plans finance outpatient cancer drug treatments. It was introduced to help keep cancer treatment and insurance premiums affordable.
MediShield Life and MediSave began covering only listed CDL treatments from 1 September 2022. The same rule applied to Integrated Shield Plans from 1 April 2023 upon policy purchase or renewal. Insurers set their own IP claim limits within this framework.
The framework has continued to evolve. From 1 October 2025, IPs cover cell, tissue and gene therapies only when they are on MOH’s separate Cell, Tissue and Gene Therapy Product list. Riders can cover non-listed treatments under a structure similar to the CDL and non-CDL split.
MOH also introduced new IP rider requirements from 1 April 2026. New riders can no longer cover the minimum IP deductible, while the annual co-payment cap rises to at least S$6,000. These changes affect deductibles and co-payment rather than non-CDL drug benefits.
If you are receiving treatment under an older policy, check your actual policy documents instead of assuming current benefits apply. MOH provided transitional arrangements for patients already receiving non-CDL treatment when the earlier changes took effect.
Read more: How MediShield Life Changes Will Affect Your Healthcare Costs
Cancer drug list Singapore coverage for Integrated Shield Plans
An Integrated Shield Plan consists of the MediShield Life component and additional private insurance coverage from an insurer. For cancer drug treatment, the CDL provides the underlying framework for MediShield Life coverage. Your IP may provide higher claim limits depending on the insurer, plan tier, and policy terms.
Assessing cancer drug coverage involves several separate checks:
- Is the treatment on the CDL?
- Does it meet the CDL’s clinical indication?
- What is the applicable MediShield Life claim limit?
- What does the IP cover above MediShield Life?
- Does an Integrated Shield Plan rider provide additional non-CDL benefits?
- How much can you pay using MediSave?
- How much might you still need to pay in cash?
These checks help distinguish whether a treatment qualifies for coverage from how much the insurer may actually reimburse.
What your Integrated Shield Plan covers for CDL cancer drugs
An IP can provide coverage above the MediShield Life component. The amount and conditions depend on your specific plan, plan tier, and any rider attached to the policy.
The MediShield Life component applies the CDL claim limit. The private insurance layer may provide a higher limit or broader benefit according to the plan terms.
A treatment being claimable does not mean the whole bill will be reimbursed. You may still have to pay for the following:
- Deductibles
- Co-insurance or co-payment
- Policy-specific limits
- Treatment-specific claim limits
- Amounts above the insurer’s claim limit
- Expenses that cannot be paid from MediSave
Your actual out-of-pocket cost therefore depends on more than whether the drug appears on the CDL.
If a patient uses more than one CDL cancer drug for the same primary cancer in a month, the CPF Board generally allows the patient to claim up to the highest applicable limit among the individual treatments, subject to the relevant rules. This determines the maximum claimable amount when several CDL drugs form part of the same month’s treatment.
Read more: Best Integrated Shield Plans in Singapore
What MediSave covers for cancer drug treatment
MediSave provides a separate source of payment for eligible cancer drug treatments, and its withdrawal limits differ from MediShield Life and IP claim limits.
Patients can use MediSave for eligible cancer drug treatments on the CDL, subject to the applicable withdrawal limits. The CPF Board currently allows patients to withdraw either S$600 or S$1,200 per month for CDL cancer drug treatments, depending on the treatment.
The CPF Board also sets separate annual MediSave withdrawal limits for cancer drug services and other cancer-related scans. These limits matter because patients may be able to withdraw a different amount from MediSave than they can claim from insurance.
A treatment may therefore have an applicable MediShield Life claim limit and a separate MediSave withdrawal limit. An IP may then provide additional coverage according to its own terms.
According to MOH, cancer drug treatments outside the CDL are not eligible for MediSave under the cancer drug treatment benefit.
Patients planning treatment can ask the hospital for an itemised estimate that shows the total cost, MediShield Life and IP claim amounts, MediSave withdrawal amount, and expected cash payment. This helps you estimate how much you may need to pay before treatment begins.
What happens if your cancer drug is not on the list?
A non-CDL treatment generally falls outside the standard cancer drug treatment benefits provided by MediShield Life, MediSave and Integrated Shield Plans. The reason a treatment falls outside the CDL matters because it determines what patients should check next.
According to MOH, cancer drug treatments not listed on the CDL are not eligible for MediShield Life, MediSave, or standard Integrated Shield Plan claims under the cancer drug treatment benefit. Some Integrated Shield Plan riders may provide coverage for selected non-CDL treatments depending on their policy terms.
A treatment can be considered non-CDL for two main reasons:
- The drug itself is not on the CDL.
- The drug appears on the CDL, but the doctor is prescribing it for an indication that the list does not cover.
MOH considers a drug a non-CDL treatment when doctors use it outside the clinical indication specified on the CDL. The distinction affects the next step.
If the CDL does not list the drug at all, the patient would need another insurance benefit to cover it. If the CDL lists the drug but not the prescribed indication, the patient should check whether the specific indication matches any CDL entry.
A separate critical illness policy works differently from an IP. Under the Monetary Authority of Singapore’s regulatory framework, an IP reimburses eligible treatment expenses while a critical illness policy pays a fixed lump sum upon a qualifying diagnosis regardless of treatment cost or CDL status.
You can use a critical illness payout for non-CDL treatment costs because CDL eligibility does not determine the payout.
Read more: Do You Need Cancer Insurance or Critical Illness Insurance in Singapore?
How an Integrated Shield Plan rider can cover non-CDL cancer drugs
IP riders can provide an additional layer of coverage for selected non-CDL cancer drugs. Without a rider, the IPs shown for all seven insurers provide S$0 for non-CDL drug coverage under the standard baseline described in the draft.
Insurers differ mainly in the non-CDL benefits provided through their riders. Benefit structures may use monthly or annual limits, and some insurers require an additional rider or add-on before the benefit applies.
The table below shows the non-CDL drug benefit available under each insurer’s cancer or outpatient care rider. Current figures should be verified directly against the insurer’s benefit schedule before making coverage decisions.
| Insurer | Plan family | Non-CDL drugs with rider | Rider name | Why it matters |
| AIA | HealthShield Gold Max | S$200,000 / year | AIA Max VitalHealth Pro | This is a yearly limit that resets at the start of each policy year. The exact amount available depends on the policyholder’s plan tier. Higher plan tiers generally come with a higher limit. |
| Great Eastern | SupremeHealth | S$200,000 / year | GREAT TotalCare 2 | This is a yearly limit. The exact amount available depends on the plan tier held by the policyholder. A lower plan tier may have a lower non-CDL benefit limit. |
| HSBC Life | Shield | S$30,000 / month | Enhanced Care ll | This limit resets every month rather than once a year. Over 12 months, this adds up to potential coverage of S$360,000 for non-CDL drugs, which is higher than the annual limits offered by most other IP insurers. |
| Income Insurance | IncomeShield | S$6,000–SS$15,000 / month | Essential Care / Optima Care | The monthly benefit differs according to the rider purchased. A policyholder on a basic rider receives S$6,000 per month, while those on a higher-tier rider receive S$15,000 per month. |
| Prudential | PRUShield | S$150,000 / year | PRUExtra | The draft notes that the non-CDL drug benefit for this plan could not be confirmed from publicly available benefit schedules as at 13 August 2026. |
| Raffles Health Insurance | Shield | S$250,000 / year | Choice rider + Cancer Guard | The S$250,000 benefit applies only when Cancer Guard was purchased as an add-on alongside the main rider. The policyholder must specifically add Cancer Guard because the policy does not include it by default. |
| Singlife | Shield Plan 1–3 | S$10,000 / month | Health Plus Plans 1, 2 and 3 | This limit resets every month. The benefit is available to policyholders with the Health Plus rider attached to their Singlife Shield plan and applies across Shield Plans 1, 2 and 3. |
Non-CDL drug benefits differ across insurers in both structure and amount. Some riders set a monthly limit that renews each month, while others use a fixed annual limit covering the full policy year.
A few plans require an additional rider or add-on before any non-CDL benefit applies. A lower monthly limit can provide more coverage over a full year than a higher annual cap, depending on how you spread treatment costs across the months.
Read more: What Is a Rider in Insurance and Should You Add One?
What to do if your cancer drug lacks coverage
A non-coverage decision alone does not explain which part of the treatment or policy led the insurer to decline the claim. First, identify the reason before estimating how much you may need to pay out of pocket.
Patients can work through the following checks:
- Ask your doctor to confirm the exact drug name, dosage, treatment indication, and whether they are using the drug alone or in combination with other treatments.
- Check the current MOH Cancer Drug List, updated 31 May 2026, to confirm whether it lists the drug and its treatment indication. Use the latest version rather than an older PDF or article.
- Ask your insurer why they did not cover the treatment. Confirm whether the drug is not on the CDL, the indication does not match, the policy excludes the treatment, or you have reached the claim limit.
- Check your IP rider to see whether it provides outpatient cancer care or non-CDL treatment benefits.
- Ask the hospital about MediSave and request the expected out-of-pocket amount. Even when a treatment is claimable, you may still face a cash shortfall. Calculate your estimated out-of-pocket cost instead of just checking whether your plan covers the treatment.
If there is a disagreement over a claim, raise it with the insurer first. MOH notes that policyholders can also bring insurance disputes to the Financial Industry Disputes Resolution Centre, which provides a formal channel for resolving disputes between policyholders and insurers.
Conclusion
Use the Cancer Drug List as a starting point to understand how Singapore finances outpatient cancer drug treatment. Your final out-of-pocket cost depends on whether the CDL lists the treatment and its clinical indication, and how much MediShield Life, your Integrated Shield Plan and rider cover.
Before starting treatment, confirm the drug, clinical indication, applicable CDL limits, IP coverage, rider benefits, MediSave withdrawal limit and expected cash payment with your doctor, hospital and insurer.
If you are unsure how your current insurance covers CDL or non-CDL cancer treatments, speak to Planner Bee about reviewing your coverage. If you are looking for an IP rider that better suits your needs, you can also submit a request for a personalised quote to compare your options.
Frequently asked questions
Is my cancer drug on the Cancer Drug List?
Check the current Cancer Drug List published by MOH to see whether your drug is included. You should also check the clinical indication, as a listed drug does not automatically qualify for coverage for every type of cancer or treatment use.
What if my doctor recommends a drug that isn’t on the list?
Cancer drug treatments outside the CDL are generally not claimable under MediShield Life, MediSave, or the standard IP cancer drug treatment benefit. However, some riders may cover selected non-CDL treatments, so check whether your rider provides benefits for non-CDL drugs or outpatient cancer care.
Does my rider cover non-CDL drugs?
It depends on your specific IP rider, as some insurers offer additional benefits for selected non-CDL treatments subject to their own terms and limits. Check your policy documents or ask your insurer whether the specific drug and clinical indication are covered.
Can I use MediSave for cancer drugs not on the list?
No, MediSave can generally be used for eligible cancer drug treatments on the CDL, subject to the applicable withdrawal limits. Cancer drug treatments outside the CDL are not eligible for MediSave under the cancer drug treatment benefit.
Does having a rider mean my cancer treatment is fully covered?
No, a rider may provide additional benefits or reduce your co-payment, but coverage remains subject to its terms, limits, and exclusions. Benefits vary between insurers and products, so check your specific policy rather than assuming your treatment is fully covered.
Does this apply to treatment I started before the changes came into effect?
MOH introduced transitional arrangements for patients already receiving non-CDL cancer treatment when the changes took effect in 2022 and 2023. If you are affected, check your policy documents for the specific transitional terms rather than assuming that current standard benefits apply.
Which insurer covers the most non-CDL drugs?
There is no straightforward way to name one insurer as covering the most non-CDL drugs because each rider has different treatment lists, limits, and conditions. The more useful approach is to check whether your specific drug and clinical indication are covered under the rider you are considering.
Do I need to change my Integrated Shield Plan if my drug isn’t covered?
Not necessarily, as you should first check why the treatment is not covered and whether your existing rider provides additional benefits. Switching or applying for another Integrated Shield Plan is subject to underwriting and may result in exclusions or other limitations, so consider the full policy implications before changing plans.
